Abstract
In the present study, we characterize the antinociceptive effects produced by the chemokine CCL4 in mice. The intraplantar administration of very low doses of CCL4 (0.1–3 pg) produced bilateral antinociception assessed by the unilateral hot-plate test (UHP) without evoking chemotactic responses at the injection site. Moreover, the subcutaneous administration of CCL4 (3–100 pg/kg) also yielded bilateral antinociception in the UHP and the paw pressure test and reduced the number of spinal neurons that express Fos protein in response to noxious stimulation. The implication of peripheral CCR5 but not CCR1 in CCL4-evoked antinociception was deduced from the inhibition produced by systemic but not intrathecal, administration of the CCR5 antagonist DAPTA, and the inefficacy of the CCR1 antagonist J113863. Besides, the inhibition observed after subcutaneous but not intrathecal administration of naloxone demonstrated the involvement of peripheral opioids and the efficacy of naltrindole but not cyprodime or nor-binaltorphimine supported the participation of δ-opioid receptors. In accordance, plasma levels of met-enkephalin, but not β-endorphin, were augmented in response to CCL4. Likewise, CCL4-evoked antinociception was blocked by the administration of an anti-met-enk antibody. Leukocyte depletion experiments performed with cyclophosphamide, anti-Ly6G, or anti-CD3 antibodies indicated that the antinociceptive effect evoked by CCL4 depends on circulating T lymphocytes. Double immunofluorescence experiments showed a four times more frequent expression of met-enk in CD4+ than in CD8+ T lymphocytes. CCL4-induced antinociception almost disappeared upon CD4+, but not CD8+, lymphocyte depletion with selective antibodies, thus supporting that the release of met-enk from CD4+ lymphocytes underlies the opioid antinociceptive response evoked by CCL4.
Similar content being viewed by others
References
Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 1843:2563–2582
Abbadie C (2005) Chemokines, chemokine receptors and pain. Trends Immunol 26:529–534
White FA, Bhangoo SK, Miller RJ (2005) Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4:834–844
Dawes JM, McMahon SB (2013) Chemokines as peripheral pain mediators. Neurosci Lett 557(Pt A):1–8
Baamonde A, Hidalgo A, Menéndez L (2011) Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1β in the spinal hyperalgesia evoked by the chemokine CCL2 in mice. Neurosci Lett 502:178–181
Akimoto N, Honda K, Uta D, Beppu K, Ushijima Y, Matsuzaki Y, Nakashima S, Kido MA et al (2013) CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury. Cell Death Dis 20(4):e679
Yin Q, Fan Q, Zhao Y, Cheng MY, Liu H, Li J, Lu FF, Jia JT et al (2015) Spinal NF-κB and chemokine ligand 5 expression during spinal glial cell activation in a neuropathic pain model. PLoS One 10:e0115120
Llorián-Salvador M, González-Rodríguez S, Lastra A, Fernández-García MT, Hidalgo A, Menéndez L, Baamonde A (2016) Involvement of CC chemokine receptor 1 and CCL3 in acute and chronic inflammatory pain in mice. Basic Clin Pharmacol Toxicol 119:32–40
Llorián-Salvador M, Pevida M, González-Rodríguez S, Lastra A, Fernández-García MT, Hidalgo A, Baamonde A, Menéndez L (2016) Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice. Fundam Clin Pharmacol 30:235–238
Zhang ZJ, Jiang BC, Gao YJ (2017) Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cell Mol Life Sci 74:3275–3291
Zhou YQ, Gao HY, Guan XH, Yuan X, Fang GG, Chen Y, Ye DW (2015) Chemokines and their receptors: Potential therapeutic targets for bone Cancer pain. Curr Pharm Des 21:5029–5033
Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027–5035
Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE et al (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100:7947–7952
Silva RL, Lopes AH, Guimarães RM, Cunha TM (2017) CXCL1/CXCR2 signaling in pathological pain: Role in peripheral and central sensitization. Neurobiol Dis 105:109–116
Xu W, Zhu M, Yuan S, Yu W (2016) Spinal CXCL5 contributes to nerve injury-induced neuropathic pain via modulating GSK-3β phosphorylation and activity in rats. Neurosci Lett 634:52–59
Yu Y, Huang X, Di Y, Qu L, Fan N (2017) Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic compression of dorsal root ganglion. Sci Rep 7:5707
Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G et al (2004) Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294–2302
Rittner HL, Brack A, Stein C (2008) The other side of the medal: how chemokines promote analgesia. Neurosci Lett 437:203–208
Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schäfer M, Stein C, Brack A (2006) Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J 20:2627–2629
Wang Y, Gehringer R, Mousa SA, Hackel D, Brack A, Rittner HL (2014) CXCL10 controls inflammatory pain via opioid peptide-containing macrophages in electroacupuncture. PLoS One 9:e94696
Kiguchi N, Kobayashi Y, Maeda T, Fukazawa Y, Tohya K, Kimura M, Kishioka S (2012) Epigenetic augmentation of the macrophage inflammatory protein 2/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J Pharmacol Exp Ther 340:577–587
Bu H, Shu B, Gao F, Liu C, Guan X, Ke C, Cao F, Hinton AO Jr et al (2014) Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat 143:255–263
González-Rodríguez S, Álvarez MG, García-Domínguez M, Lastra A, Cernuda-Cernuda R, Folgueras AR, Fernández-García MT, Hidalgo A et al (2017) Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice. Brain Behav Immun 62:151–161
Oliveira SH, Lira S, Martinez AC, Wiekowski M, Sullivan L, Lukacs NW (2002) Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J Leukoc Biol 71:1019–1025
Appelberg R (1992) Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J Leukoc Biol 52:303–306
Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177:1821–1826
Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M (1995) Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 25:64–68
Saika F, Kiguchi N, Kobayashi Y, Fukazawa Y, Kishioka S (2012) CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury. Eur J Pain 16:1271–1280
Guo W, Imai S, Yang JL, Zou S, Watanabe M, Chu YX, Mohammad Z, Xu H et al (2017) In vivo immune interactions of multipotent stromal cells underlie their long-lasting pain-relieving effect. Sci Rep 7:10107
Dejima T, Shibata K, Yamada H, Hara H, Iwakura Y, Naito S, Yoshikai Y (2011) Protective role of naturally occurring interleukin-17A-producing γ δ T cells in the lung at the early stage of systemic candidiasis in mice. Infect Immun 79:4503–4510
Loubaki L, Tremblay T, Bazin R (2013) In vivo depletion of leukocytes and platelets following injection of T cell-specific antibodies into mice. J Immunol Methods 393:38–44
González-Rodríguez S, Llames S, Hidalgo A, Baamonde A, Menéndez L (2012) Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice. Fundam Clin Pharmacol 26:363–372
Baamonde A, Curto-Reyes V, Juárez L, Meana A, Hidalgo A, Menéndez L (2007) Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice. Life Sci 81:673–682
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63
Baamonde A, Lastra A, Fresno MF, Llames S, Meana A, Hidalgo A, Menéndez L (2004) Implantation of tumoral XC cells induces chronic, endothelin-dependent, thermal hyperalgesia in mice. Cell Mol Neurobiol 24:269–281
Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409–419
Biddolph SC, Gatter KC (1999) Immunohistochemistry of lymphoid organs. In: Rowland-Jones SL, McMichael AJ (eds) Lymphocytes. A practical approach, 2nd edn. Oxford University Press, Oxford, p. 30
Cabot PJ, Carter L, Schäfer M, Stein C (2001) Methionine enkephalin and dynorphin A release from immune cells and control of inflammatory pain. Pain 93:207–212
Lu P, Nakamoto Y, Nemoto-Sasaki Y, Fujii C, Wang H, Hashii M, Ohmoto Y, Kaneko S et al (2003) Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 162:1249–1258
Repeke CE, Ferreira SB Jr, Claudino M, Silveira EM, de Assis GF, Avila-Campos MJ, Silva JS, Garlet GP (2010) Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 46:1122–1130
Chou CC, Fine JS, Pugliese-Sivo C, Gonsiorek W, Davies L, Deno G, Petro M, Schwarz M et al (2002) Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta. Br J Pharmacol 137:663–675
Alkhatib G (2009) The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4:96–103
Chang TT, Chen JW (2016) Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? Cardiovasc Diabetol 15:117
Pevida M, Lastra A, Meana Á, Hidalgo A, Baamonde A, Menéndez L (2014) The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells. Neuroscience 259:113–125
Hang LH, Li SN, Dan X, Shu WW, Luo H, Shao DH (2017) Involvement of spinal CCR5/PKCγ signaling pathway in the maintenance of cancer-induced bone pain. Neurochem Res 42:563–571
Heyman JS, Koslo RJ, Mosberg HI, Tallarida RJ, Porreca F (1986) Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists. Life Sci 39:1795–1803
Mansour A, Hoversten MT, Taylor LP, Watson SJ, Akil H (1995) The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res 700:89–98
Padrós MR, Vindrola O, Zunszain P, Fainboin L, Finkielman S, Nahmod VE (1989) Mitogenic activation of the human lymphocytes induce the release of proenkephalin derived peptides. Life Sci 45:1805–1811
Figuerola ML, Vindrola O, Barontini MB, Leston JA (1991) Changes in neutrophil Met-Enk containing peptides in episodic cluster headache. Headache 31:406–408
Hook S, Camberis M, Prout M, Konig M, Zimmer A, Van Heeke G, Le Gros G (1999) Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro. Immunol Cell Biol 77:385–390
Shan F, Xia Y, Wang N, Meng J, Lu C, Meng Y, Plotnikoff NP (2011) Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 32:929–937
Hua H, Lu C, Li W, Meng J, Wang D, Plotnikoff NP, Wang E, Shan F (2012) Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ. Hum Vaccin Immunother 8:1082–1089
Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2:1126–1132
Boué J, Blanpied C, Brousset P, Vergnolle N, Dietrich G (2011) Endogenous opioid-mediated analgesia is dependent on adaptive T cell response in mice. J Immunol 186:5078–5084
Boué J, Blanpied C, Djata-Cabral M, Pelletier L, Vergnolle N, Dietrich G (2012) Immune conditions associated with CD4+ T effector-induced opioid release and analgesia. Pain 153:485–493
Krzysiek R, Lefèvre EA, Zou W, Foussat A, Bernard J, Portier A, Galanaud P, Richard Y (1999) Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cell. J Immunol 162:4455–4463
Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391:344–345
Askew D, Su CA, Barkauskas DS, Dorand RD, Myers J, Liou R, Nthale J, Huang AY (2016) Transient surface CCR5 expression by naive CD8+ T cells within inflamed lymph nodes is dependent on high endothelial venule interaction and augments Th cell-dependent memory response. J Immunol 196:3653–3664
Basso L, Boué J, Mahiddine K, Blanpied C, Robiou-du-Pont S, Vergnolle N, Deraison C, Dietrich G (2016) Endogenous analgesia mediated by CD4+ T lymphocytes is dependent on Enks in mice. J Neuroinflammation 13:132
Noble F, Turcaud S, Fournié-Zaluski MC, Roques BP (1992) Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine. Eur J Pharmacol 223:83–89
Acknowledgements
Grants were provided by the Ministerio de Economía, Industria y Competitividad, and FEDER (European Union) (SAF2017-86799-R). IUOPA is supported by Obra Social Fundación Cajastur-Liberbank (Asturias, Spain). M.G.D. is granted by a FPU predoctoral fellowship (FPU13-04585, MECD, Spain). A.R.F. is recipient of a Ramón y Cajal Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García-Domínguez, M., Lastra, A., Folgueras, A.R. et al. The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4+ Lymphocytes and Met-Enkephalin. Mol Neurobiol 56, 1578–1595 (2019). https://doi.org/10.1007/s12035-018-1176-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1176-8